| Dr Eugene Stanley Olsowka, MD, PHD | |
|
9460 S Saginaw Rd Ste D, Grand Blanc, MI 48439-8207 | |
| (810) 733-7741 | |
| (810) 733-8898 |
| Full Name | Dr Eugene Stanley Olsowka |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 40 Years |
| Location | 9460 S Saginaw Rd Ste D, Grand Blanc, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407943871 | NPI | - | NPPES |
| 1407943871 | Medicaid | MI | |
| 4116480 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 4301063271 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Covenant Medical Center | Saginaw, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Flint Clinical Pathologist Pc | 2365419454 | 22 |
| Hills And Dales General Hospital Inc | 8022910363 | 34 |
News Archive
Pharmasset, Inc. announced today that dosing has begun in a Phase 2b study of PSI-7977, a nucleotide analog polymerase inhibitor for the treatment of chronic hepatitis C (HCV). The trial will evaluate PSI-7977 200mg QD and 400mg QD in combination with pegylated interferon alfa 2a and ribavirin, the current standard of care (SOC) in patients with HCV genotype 1 who have not been treated previously.
Researchers at the University of Michigan Comprehensive Cancer Center have found that a type of normal stem cell fuels ovarian cancer by encouraging cancer stem cells to grow.
"International relief officials reported an increasingly grim aid crisis stemming from the Syria conflict on Tuesday, with two million people there not getting desperately needed help, and a sudden acceleration of refugees overwhelming the ability of neighboring countries to absorb them," the New York Times reports.
New case studies show the benefits of remote management based on continuous glucose monitoring (CGM) and telemedicine visits for patients with type 1 and type 2 diabetes during the COVID-19 pandemic.
› Verified 1 days ago
| Entity Name | Hills & Dales General Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154367001 PECOS PAC ID: 8022910363 Enrollment ID: O20040126000677 |
News Archive
Pharmasset, Inc. announced today that dosing has begun in a Phase 2b study of PSI-7977, a nucleotide analog polymerase inhibitor for the treatment of chronic hepatitis C (HCV). The trial will evaluate PSI-7977 200mg QD and 400mg QD in combination with pegylated interferon alfa 2a and ribavirin, the current standard of care (SOC) in patients with HCV genotype 1 who have not been treated previously.
Researchers at the University of Michigan Comprehensive Cancer Center have found that a type of normal stem cell fuels ovarian cancer by encouraging cancer stem cells to grow.
"International relief officials reported an increasingly grim aid crisis stemming from the Syria conflict on Tuesday, with two million people there not getting desperately needed help, and a sudden acceleration of refugees overwhelming the ability of neighboring countries to absorb them," the New York Times reports.
New case studies show the benefits of remote management based on continuous glucose monitoring (CGM) and telemedicine visits for patients with type 1 and type 2 diabetes during the COVID-19 pandemic.
› Verified 1 days ago
| Entity Name | Marlette Regional Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598840498 PECOS PAC ID: 3971408121 Enrollment ID: O20040225000161 |
News Archive
Pharmasset, Inc. announced today that dosing has begun in a Phase 2b study of PSI-7977, a nucleotide analog polymerase inhibitor for the treatment of chronic hepatitis C (HCV). The trial will evaluate PSI-7977 200mg QD and 400mg QD in combination with pegylated interferon alfa 2a and ribavirin, the current standard of care (SOC) in patients with HCV genotype 1 who have not been treated previously.
Researchers at the University of Michigan Comprehensive Cancer Center have found that a type of normal stem cell fuels ovarian cancer by encouraging cancer stem cells to grow.
"International relief officials reported an increasingly grim aid crisis stemming from the Syria conflict on Tuesday, with two million people there not getting desperately needed help, and a sudden acceleration of refugees overwhelming the ability of neighboring countries to absorb them," the New York Times reports.
New case studies show the benefits of remote management based on continuous glucose monitoring (CGM) and telemedicine visits for patients with type 1 and type 2 diabetes during the COVID-19 pandemic.
› Verified 1 days ago
| Entity Name | Mckenzie Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497750608 PECOS PAC ID: 6406755289 Enrollment ID: O20040310000552 |
News Archive
Pharmasset, Inc. announced today that dosing has begun in a Phase 2b study of PSI-7977, a nucleotide analog polymerase inhibitor for the treatment of chronic hepatitis C (HCV). The trial will evaluate PSI-7977 200mg QD and 400mg QD in combination with pegylated interferon alfa 2a and ribavirin, the current standard of care (SOC) in patients with HCV genotype 1 who have not been treated previously.
Researchers at the University of Michigan Comprehensive Cancer Center have found that a type of normal stem cell fuels ovarian cancer by encouraging cancer stem cells to grow.
"International relief officials reported an increasingly grim aid crisis stemming from the Syria conflict on Tuesday, with two million people there not getting desperately needed help, and a sudden acceleration of refugees overwhelming the ability of neighboring countries to absorb them," the New York Times reports.
New case studies show the benefits of remote management based on continuous glucose monitoring (CGM) and telemedicine visits for patients with type 1 and type 2 diabetes during the COVID-19 pandemic.
› Verified 1 days ago
| Entity Name | Scheurer Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104016849 PECOS PAC ID: 1456242296 Enrollment ID: O20040827000155 |
News Archive
Pharmasset, Inc. announced today that dosing has begun in a Phase 2b study of PSI-7977, a nucleotide analog polymerase inhibitor for the treatment of chronic hepatitis C (HCV). The trial will evaluate PSI-7977 200mg QD and 400mg QD in combination with pegylated interferon alfa 2a and ribavirin, the current standard of care (SOC) in patients with HCV genotype 1 who have not been treated previously.
Researchers at the University of Michigan Comprehensive Cancer Center have found that a type of normal stem cell fuels ovarian cancer by encouraging cancer stem cells to grow.
"International relief officials reported an increasingly grim aid crisis stemming from the Syria conflict on Tuesday, with two million people there not getting desperately needed help, and a sudden acceleration of refugees overwhelming the ability of neighboring countries to absorb them," the New York Times reports.
New case studies show the benefits of remote management based on continuous glucose monitoring (CGM) and telemedicine visits for patients with type 1 and type 2 diabetes during the COVID-19 pandemic.
› Verified 1 days ago
| Entity Name | Harbor Beach Community Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619059458 PECOS PAC ID: 7214903483 Enrollment ID: O20040908001458 |
News Archive
Pharmasset, Inc. announced today that dosing has begun in a Phase 2b study of PSI-7977, a nucleotide analog polymerase inhibitor for the treatment of chronic hepatitis C (HCV). The trial will evaluate PSI-7977 200mg QD and 400mg QD in combination with pegylated interferon alfa 2a and ribavirin, the current standard of care (SOC) in patients with HCV genotype 1 who have not been treated previously.
Researchers at the University of Michigan Comprehensive Cancer Center have found that a type of normal stem cell fuels ovarian cancer by encouraging cancer stem cells to grow.
"International relief officials reported an increasingly grim aid crisis stemming from the Syria conflict on Tuesday, with two million people there not getting desperately needed help, and a sudden acceleration of refugees overwhelming the ability of neighboring countries to absorb them," the New York Times reports.
New case studies show the benefits of remote management based on continuous glucose monitoring (CGM) and telemedicine visits for patients with type 1 and type 2 diabetes during the COVID-19 pandemic.
› Verified 1 days ago
| Entity Name | Flint Clinical Pathologist Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568570471 PECOS PAC ID: 2365419454 Enrollment ID: O20040916001168 |
News Archive
Pharmasset, Inc. announced today that dosing has begun in a Phase 2b study of PSI-7977, a nucleotide analog polymerase inhibitor for the treatment of chronic hepatitis C (HCV). The trial will evaluate PSI-7977 200mg QD and 400mg QD in combination with pegylated interferon alfa 2a and ribavirin, the current standard of care (SOC) in patients with HCV genotype 1 who have not been treated previously.
Researchers at the University of Michigan Comprehensive Cancer Center have found that a type of normal stem cell fuels ovarian cancer by encouraging cancer stem cells to grow.
"International relief officials reported an increasingly grim aid crisis stemming from the Syria conflict on Tuesday, with two million people there not getting desperately needed help, and a sudden acceleration of refugees overwhelming the ability of neighboring countries to absorb them," the New York Times reports.
New case studies show the benefits of remote management based on continuous glucose monitoring (CGM) and telemedicine visits for patients with type 1 and type 2 diabetes during the COVID-19 pandemic.
› Verified 1 days ago
| Entity Name | Flint Medical Laboratory Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760590665 PECOS PAC ID: 6103848353 Enrollment ID: O20051230000564 |
News Archive
Pharmasset, Inc. announced today that dosing has begun in a Phase 2b study of PSI-7977, a nucleotide analog polymerase inhibitor for the treatment of chronic hepatitis C (HCV). The trial will evaluate PSI-7977 200mg QD and 400mg QD in combination with pegylated interferon alfa 2a and ribavirin, the current standard of care (SOC) in patients with HCV genotype 1 who have not been treated previously.
Researchers at the University of Michigan Comprehensive Cancer Center have found that a type of normal stem cell fuels ovarian cancer by encouraging cancer stem cells to grow.
"International relief officials reported an increasingly grim aid crisis stemming from the Syria conflict on Tuesday, with two million people there not getting desperately needed help, and a sudden acceleration of refugees overwhelming the ability of neighboring countries to absorb them," the New York Times reports.
New case studies show the benefits of remote management based on continuous glucose monitoring (CGM) and telemedicine visits for patients with type 1 and type 2 diabetes during the COVID-19 pandemic.
› Verified 1 days ago
| Entity Name | Marlette Regional Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1346325214 PECOS PAC ID: 3971408121 Enrollment ID: O20070223000678 |
News Archive
Pharmasset, Inc. announced today that dosing has begun in a Phase 2b study of PSI-7977, a nucleotide analog polymerase inhibitor for the treatment of chronic hepatitis C (HCV). The trial will evaluate PSI-7977 200mg QD and 400mg QD in combination with pegylated interferon alfa 2a and ribavirin, the current standard of care (SOC) in patients with HCV genotype 1 who have not been treated previously.
Researchers at the University of Michigan Comprehensive Cancer Center have found that a type of normal stem cell fuels ovarian cancer by encouraging cancer stem cells to grow.
"International relief officials reported an increasingly grim aid crisis stemming from the Syria conflict on Tuesday, with two million people there not getting desperately needed help, and a sudden acceleration of refugees overwhelming the ability of neighboring countries to absorb them," the New York Times reports.
New case studies show the benefits of remote management based on continuous glucose monitoring (CGM) and telemedicine visits for patients with type 1 and type 2 diabetes during the COVID-19 pandemic.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Eugene Stanley Olsowka, MD, PHD 9460 S Saginaw Rd Ste D, Grand Blanc, MI 48439-8207 Ph: (810) 733-7741 | Dr Eugene Stanley Olsowka, MD, PHD 9460 S Saginaw Rd Ste D, Grand Blanc, MI 48439-8207 Ph: (810) 733-7741 |
News Archive
Pharmasset, Inc. announced today that dosing has begun in a Phase 2b study of PSI-7977, a nucleotide analog polymerase inhibitor for the treatment of chronic hepatitis C (HCV). The trial will evaluate PSI-7977 200mg QD and 400mg QD in combination with pegylated interferon alfa 2a and ribavirin, the current standard of care (SOC) in patients with HCV genotype 1 who have not been treated previously.
Researchers at the University of Michigan Comprehensive Cancer Center have found that a type of normal stem cell fuels ovarian cancer by encouraging cancer stem cells to grow.
"International relief officials reported an increasingly grim aid crisis stemming from the Syria conflict on Tuesday, with two million people there not getting desperately needed help, and a sudden acceleration of refugees overwhelming the ability of neighboring countries to absorb them," the New York Times reports.
New case studies show the benefits of remote management based on continuous glucose monitoring (CGM) and telemedicine visits for patients with type 1 and type 2 diabetes during the COVID-19 pandemic.
› Verified 1 days ago
Doina David, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 9460 S Saginaw Rd Ste D, Grand Blanc, MI 48439 Phone: 810-733-7741 Fax: 810-733-8898 | |
Dr. Khushi Sweety Lokesh Nagori, MBBS Pathology Medicare: Accepting Medicare Assignments Practice Location: 9460 S Saginaw Rd Ste D, Grand Blanc, MI 48439 Phone: 810-733-7741 | |
Baraa Alosh, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 9460 S Saginaw Rd Ste D, Grand Blanc, MI 48439 Phone: 810-733-7741 Fax: 810-733-7741 | |
Alan F Henke, DO Pathology Medicare: Accepting Medicare Assignments Practice Location: 1 Genesys Pkwy, Grand Blanc, MI 48439 Phone: 810-606-5560 | |
Moutaz Haiba, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 9460 S Saginaw Rd Ste D, Grand Blanc, MI 48439 Phone: 810-733-7741 Fax: 810-733-8898 | |
Majd Jundi, MD Pathology Medicare: Medicare Enrolled Practice Location: 9460 S Saginaw Rd Ste D, Grand Blanc, MI 48439 Phone: 810-733-7741 | |
Dr. Daniel Joseph Cowden, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 9460 S Saginaw Rd Ste D, Grand Blanc, MI 48439 Phone: 810-733-7741 |